Navigation Links
DaVita CEO Kent Thiry Honored as One of Modern Healthcare's 100 Most Powerful People in Healthcare
Date:8/31/2009

DENVER, Aug. 31 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced that Modern Healthcare Magazine, one of the nation's leading health care industry publications, named Kent Thiry, Chairman and CEO for DaVita(R), as one of the 100 Most Powerful People in Healthcare in 2009.

(Logo:http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

Modern Healthcare's annual award recognizes the leaders and organizations that are considered among the most influential in the industry and aim to reshape our nation's health care system. The 100 winners were chosen by the readers of Modern Healthcare from among more than 25,700 nominations.

Thiry has ranked among the Modern Healthcare "Most Powerful" two years in a row and is the only kidney-care leader to make the list in 2009. Thiry leads more than 34,000 DaVita teammates (employees) nationwide, all working to provide superior patient care and exemplify the company's Mission and Core Values.

"This honor reflects the exceptional work that our teammates do every day to improve patients' lives," Thiry said. "Our teammates deliver ground-breaking innovative care through Village Health and DaVita Rx and are vocal advocates for kidney patients in Washington, DC, and in state capitols across the nation."

In addition to consistently setting industry benchmarks for clinical outcomes, DaVita is a pioneer in the area of corporate social responsibility. DaVita has developed more than 30 philanthropic, community and social programs to support the company's "Trilogy of Care" - caring for our patients, caring for our teammates, and caring for the world. DaVita launched its first annual Community Care report in June 2009 by hosting 10 community service projects across the country.

DaVita is a registered trademark of DaVita Inc. All other trademarks are the property of their respective owners.

About DaVita Inc.

DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita has been recognized as the only FORTUNE 500(R) company on WorldBlu's annual List of Most Democratic Workplaces(TM). As of June 30, 2009, DaVita operated or provided administrative services at 1,493 outpatient dialysis facilities and acute units in approximately 700 hospitals located in 43 states and the District of Columbia, serving approximately 116,000 patients. As part of DaVita's commitment to building a healthy, caring community, DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment. For more information about DaVita, its kidney education materials and its community programs, please visit www.davita.com.


'/>"/>
SOURCE DaVita Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. DaVita Offers Dialysis While Patients Sleep
2. DaVita to Present Three Abstracts for the International Society for Peritoneal Dialysis
3. The City of Tacoma Announces Official DaVita Day
4. DaVita Only Dialysis Provider Named on EPAs FORTUNE 500 List of Green Power Purchasers
5. DaVita Hosts National Quality Week 2009
6. DaVita Donates Toys, Shoes and School Supplies for Army National Guard to Distribute in Iraq
7. Mayor Julian Jolly Reseueollo Dialysis Center Officially Opens Doors With Support From Bridge of Life - DaVita Medical Missions
8. Six DaVita Clinics in Colorado Receive Silver Award for Clinical Excellence
9. DaVita Clinical Research Appoints Mahesh Krishnan as Vice President
10. DaVitas Award-Winning Training Program for New Teammates Reaches Milestone With 100th DaVita Academy in Baltimore, Maryland
11. DaVita Celebrates the Opening of Its 1,500th Outpatient Kidney Care Clinic in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... June 25, 2017 , ... CareSet Labs released the Root ... Orleans. This is a new, greatly improved version of the Doctor Referral teaming dataset ... by Fred Trotter and subsequently called the the “Doctor Referral Dataset” as released by ...
(Date:6/24/2017)... York (PRWEB) , ... June 24, 2017 , ... ... the Dental365 family. Located at 217 Portion Road in Lake Ronkonkoma, Dental365 offers ... evenings and weekends so that visits to the dentist fit into their patients’ ...
(Date:6/23/2017)... ... 23, 2017 , ... By scoring 100% for fiscal management and accountability, the ... online charity evaluator, Charity Navigator, validating ANRF's work as a top charity in America. ... Charity Navigator and earns ANRF a spot on their “ 10 Charities Worth Watching ...
(Date:6/23/2017)... ... 2017 , ... Military Connection friend and veteran advocate Micaela Bensko ... Atlantic lounge. , Bensko is no stranger to the plight of the disabled. ... life to supporting our wounded veterans. A world-class photographer, her riveting photos “The Wounds ...
(Date:6/23/2017)... ... 2017 , ... Georgia State University will host the First ... two-day conference is focused on advancing scientific knowledge about the aggressive triple negative ... racial breast cancer-related disparities. The conference theme is “Illuminating Actionable Biology.” , Conference ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. (ASX: ... on the design, manufacture, sale and distribution of the ... the progress of its commercial roll-out in ... in more than one hundred (100) medical institutions and ... AeroForm offers a needle-free alternative for women who choose ...
(Date:6/7/2017)... Endo International plc (NASDAQ: ENDP ) today ... R. Goodwin , U.S. District Court Judge for the ... entered a case management order in MDL 2325, American ... (the "MDL") that includes a provision requiring plaintiffs in ... specific causation within one hundred twenty (120) days of ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly and ... that results from the Phase 3 MONARCH 2 ... & 6 inhibitor, in combination with fulvestrant, significantly ... fulvestrant alone in women with hormone-receptor-positive (HR+), human ... cancer who have relapsed or progressed after endocrine ...
Breaking Medicine Technology: